_version_ 1784723050190602240
author Xu, Xingli
Liao, Yun
Jiang, Guorun
Yao, Weiguo
Duan, Suqin
Xiao, Kang
Ding, Xuefeng
Zhao, Heng
Zhang, Yujian
Zhang, Aihua
Yang, Jingsi
Che, Yanchun
Zhang, Jun
Zhao, Fanfan
Ma, Xiaopin
Zhao, Zhimei
Cui, Pingfang
Yang, Xiaolei
Lin, Xiaorui
Cai, Wei
Yan, Jiao
Yang, Zhenqing
Qiu, Heng
Zhang, Jing
Huang, Lei
Shen, Mingyun
Zhao, Guofeng
Yu, Li
Li, Dandan
Fan, Shengtao
Zhang, Ying
Wang, Lichun
He, Licun
Dong, Fei
Xu, Wenbo
Li, Hangwen
Li, Qihan
author_facet Xu, Xingli
Liao, Yun
Jiang, Guorun
Yao, Weiguo
Duan, Suqin
Xiao, Kang
Ding, Xuefeng
Zhao, Heng
Zhang, Yujian
Zhang, Aihua
Yang, Jingsi
Che, Yanchun
Zhang, Jun
Zhao, Fanfan
Ma, Xiaopin
Zhao, Zhimei
Cui, Pingfang
Yang, Xiaolei
Lin, Xiaorui
Cai, Wei
Yan, Jiao
Yang, Zhenqing
Qiu, Heng
Zhang, Jing
Huang, Lei
Shen, Mingyun
Zhao, Guofeng
Yu, Li
Li, Dandan
Fan, Shengtao
Zhang, Ying
Wang, Lichun
He, Licun
Dong, Fei
Xu, Wenbo
Li, Hangwen
Li, Qihan
author_sort Xu, Xingli
collection PubMed
description
format Online
Article
Text
id pubmed-9178391
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-91783912022-06-13 Immunological evaluation of an mRNA vaccine booster in individuals fully immunized with an inactivated SARS‐CoV‐2 vaccine Xu, Xingli Liao, Yun Jiang, Guorun Yao, Weiguo Duan, Suqin Xiao, Kang Ding, Xuefeng Zhao, Heng Zhang, Yujian Zhang, Aihua Yang, Jingsi Che, Yanchun Zhang, Jun Zhao, Fanfan Ma, Xiaopin Zhao, Zhimei Cui, Pingfang Yang, Xiaolei Lin, Xiaorui Cai, Wei Yan, Jiao Yang, Zhenqing Qiu, Heng Zhang, Jing Huang, Lei Shen, Mingyun Zhao, Guofeng Yu, Li Li, Dandan Fan, Shengtao Zhang, Ying Wang, Lichun He, Licun Dong, Fei Xu, Wenbo Li, Hangwen Li, Qihan Clin Transl Med Letter to Editor John Wiley and Sons Inc. 2022-06-09 /pmc/articles/PMC9178391/ /pubmed/35678117 http://dx.doi.org/10.1002/ctm2.875 Text en © 2022 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to Editor
Xu, Xingli
Liao, Yun
Jiang, Guorun
Yao, Weiguo
Duan, Suqin
Xiao, Kang
Ding, Xuefeng
Zhao, Heng
Zhang, Yujian
Zhang, Aihua
Yang, Jingsi
Che, Yanchun
Zhang, Jun
Zhao, Fanfan
Ma, Xiaopin
Zhao, Zhimei
Cui, Pingfang
Yang, Xiaolei
Lin, Xiaorui
Cai, Wei
Yan, Jiao
Yang, Zhenqing
Qiu, Heng
Zhang, Jing
Huang, Lei
Shen, Mingyun
Zhao, Guofeng
Yu, Li
Li, Dandan
Fan, Shengtao
Zhang, Ying
Wang, Lichun
He, Licun
Dong, Fei
Xu, Wenbo
Li, Hangwen
Li, Qihan
Immunological evaluation of an mRNA vaccine booster in individuals fully immunized with an inactivated SARS‐CoV‐2 vaccine
title Immunological evaluation of an mRNA vaccine booster in individuals fully immunized with an inactivated SARS‐CoV‐2 vaccine
title_full Immunological evaluation of an mRNA vaccine booster in individuals fully immunized with an inactivated SARS‐CoV‐2 vaccine
title_fullStr Immunological evaluation of an mRNA vaccine booster in individuals fully immunized with an inactivated SARS‐CoV‐2 vaccine
title_full_unstemmed Immunological evaluation of an mRNA vaccine booster in individuals fully immunized with an inactivated SARS‐CoV‐2 vaccine
title_short Immunological evaluation of an mRNA vaccine booster in individuals fully immunized with an inactivated SARS‐CoV‐2 vaccine
title_sort immunological evaluation of an mrna vaccine booster in individuals fully immunized with an inactivated sars‐cov‐2 vaccine
topic Letter to Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178391/
https://www.ncbi.nlm.nih.gov/pubmed/35678117
http://dx.doi.org/10.1002/ctm2.875
work_keys_str_mv AT xuxingli immunologicalevaluationofanmrnavaccineboosterinindividualsfullyimmunizedwithaninactivatedsarscov2vaccine
AT liaoyun immunologicalevaluationofanmrnavaccineboosterinindividualsfullyimmunizedwithaninactivatedsarscov2vaccine
AT jiangguorun immunologicalevaluationofanmrnavaccineboosterinindividualsfullyimmunizedwithaninactivatedsarscov2vaccine
AT yaoweiguo immunologicalevaluationofanmrnavaccineboosterinindividualsfullyimmunizedwithaninactivatedsarscov2vaccine
AT duansuqin immunologicalevaluationofanmrnavaccineboosterinindividualsfullyimmunizedwithaninactivatedsarscov2vaccine
AT xiaokang immunologicalevaluationofanmrnavaccineboosterinindividualsfullyimmunizedwithaninactivatedsarscov2vaccine
AT dingxuefeng immunologicalevaluationofanmrnavaccineboosterinindividualsfullyimmunizedwithaninactivatedsarscov2vaccine
AT zhaoheng immunologicalevaluationofanmrnavaccineboosterinindividualsfullyimmunizedwithaninactivatedsarscov2vaccine
AT zhangyujian immunologicalevaluationofanmrnavaccineboosterinindividualsfullyimmunizedwithaninactivatedsarscov2vaccine
AT zhangaihua immunologicalevaluationofanmrnavaccineboosterinindividualsfullyimmunizedwithaninactivatedsarscov2vaccine
AT yangjingsi immunologicalevaluationofanmrnavaccineboosterinindividualsfullyimmunizedwithaninactivatedsarscov2vaccine
AT cheyanchun immunologicalevaluationofanmrnavaccineboosterinindividualsfullyimmunizedwithaninactivatedsarscov2vaccine
AT zhangjun immunologicalevaluationofanmrnavaccineboosterinindividualsfullyimmunizedwithaninactivatedsarscov2vaccine
AT zhaofanfan immunologicalevaluationofanmrnavaccineboosterinindividualsfullyimmunizedwithaninactivatedsarscov2vaccine
AT maxiaopin immunologicalevaluationofanmrnavaccineboosterinindividualsfullyimmunizedwithaninactivatedsarscov2vaccine
AT zhaozhimei immunologicalevaluationofanmrnavaccineboosterinindividualsfullyimmunizedwithaninactivatedsarscov2vaccine
AT cuipingfang immunologicalevaluationofanmrnavaccineboosterinindividualsfullyimmunizedwithaninactivatedsarscov2vaccine
AT yangxiaolei immunologicalevaluationofanmrnavaccineboosterinindividualsfullyimmunizedwithaninactivatedsarscov2vaccine
AT linxiaorui immunologicalevaluationofanmrnavaccineboosterinindividualsfullyimmunizedwithaninactivatedsarscov2vaccine
AT caiwei immunologicalevaluationofanmrnavaccineboosterinindividualsfullyimmunizedwithaninactivatedsarscov2vaccine
AT yanjiao immunologicalevaluationofanmrnavaccineboosterinindividualsfullyimmunizedwithaninactivatedsarscov2vaccine
AT yangzhenqing immunologicalevaluationofanmrnavaccineboosterinindividualsfullyimmunizedwithaninactivatedsarscov2vaccine
AT qiuheng immunologicalevaluationofanmrnavaccineboosterinindividualsfullyimmunizedwithaninactivatedsarscov2vaccine
AT zhangjing immunologicalevaluationofanmrnavaccineboosterinindividualsfullyimmunizedwithaninactivatedsarscov2vaccine
AT huanglei immunologicalevaluationofanmrnavaccineboosterinindividualsfullyimmunizedwithaninactivatedsarscov2vaccine
AT shenmingyun immunologicalevaluationofanmrnavaccineboosterinindividualsfullyimmunizedwithaninactivatedsarscov2vaccine
AT zhaoguofeng immunologicalevaluationofanmrnavaccineboosterinindividualsfullyimmunizedwithaninactivatedsarscov2vaccine
AT yuli immunologicalevaluationofanmrnavaccineboosterinindividualsfullyimmunizedwithaninactivatedsarscov2vaccine
AT lidandan immunologicalevaluationofanmrnavaccineboosterinindividualsfullyimmunizedwithaninactivatedsarscov2vaccine
AT fanshengtao immunologicalevaluationofanmrnavaccineboosterinindividualsfullyimmunizedwithaninactivatedsarscov2vaccine
AT zhangying immunologicalevaluationofanmrnavaccineboosterinindividualsfullyimmunizedwithaninactivatedsarscov2vaccine
AT wanglichun immunologicalevaluationofanmrnavaccineboosterinindividualsfullyimmunizedwithaninactivatedsarscov2vaccine
AT helicun immunologicalevaluationofanmrnavaccineboosterinindividualsfullyimmunizedwithaninactivatedsarscov2vaccine
AT dongfei immunologicalevaluationofanmrnavaccineboosterinindividualsfullyimmunizedwithaninactivatedsarscov2vaccine
AT xuwenbo immunologicalevaluationofanmrnavaccineboosterinindividualsfullyimmunizedwithaninactivatedsarscov2vaccine
AT lihangwen immunologicalevaluationofanmrnavaccineboosterinindividualsfullyimmunizedwithaninactivatedsarscov2vaccine
AT liqihan immunologicalevaluationofanmrnavaccineboosterinindividualsfullyimmunizedwithaninactivatedsarscov2vaccine